Recent Finacing
Recent Raise
DISCO Pharmaceuticals develops surfaceome-guided antibody-drug conjugates and T-cell engagers for hard-to-treat cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at DISCO Pharmaceuticals.
